The effect on cytokine under use high-dose remifentanil in laparoscopic rectal - colon surgery

The effect on cytokine under use high-dose remifentanil in laparoscopic rectal - colon surgery - The effect on cytokine under use high-dose remifentanil in laparoscopic rectal - colon surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019609

Enrollment

Registered

2015-11-05

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon-rectal cancer

Interventions

Administration concentration is the High-dose group is 1gamma Administration concentration is the control group 0.25gamma

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in adults , in the cooperative patient to understand the significance of taking part in a clinical intervention study of ASA PS 1 or 2

Exclusion criteria

Exclusion criteria: Patients with diabetes , autoimmune diseases , taking oral steroid

Design outcomes

Primary

Measure	Time frame
Cortisol and TNF-alpha and IL-6 concentration in the blood before start and after anesthesia and after the surgery vital sign durig the surgery	—

Countries

Japan

Contacts

Public ContactTsuasa Kochiyama

Juntendo university urayasu hospital Anesthesiology

tsukasa.coach.1109@gmail.com047-353-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026